Certified by Founder Lodge
Brixton Biosciences
United States - Cambridge, MA
START UP
1 Disclosed Funding Rounds $33,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Brixton Biosciences is a clinical-stage life sciences company developing novel therapies for chronic and acute pain.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 15 ,2024 | Series B | $33,000,000 |
SV Health Investors
Schooner Capital
CHV
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
